The 11th annual Amgen Tour of California presented by AEG entered its second decade as America's most prestigious annual cycling event, welcoming an unsurpassed field of professional teams for the race start in San Diego. One of the most important races on the international calendar, the 8'day event attracts some of the brightest cycling stars in the world to the golden state each May. This year’s field features 11 World Champions, five Olympic medalists and Rio Olympic hopefuls, with more than 30 countries represented.
The 2016 Amgen Tour of California includes 10 UCI WorldTour Teams, the most in race history, as some of the top cyclists in the world face off across nearly 800 miles of California terrain May 15-22, visiting 12 Host Cities from San Diego to Sacramento.
2016 marks the debut of the UCI Women's WorldTour, which brings the highest level of professional women's cycling competition to cities around the world. The four-day Amgen Breakaway from Heart Disease Women's Race Empowered with SRAM May 19-22 marks the U.S. debut of the Women’s WorldTour and will showcase some of the best talent in the sport. The peloton will include two-time Olympic champion Kristin Armstrong and eight Rio Olympic hopefuls.
The eight-stage men’s event began Sunday with 18 of the world’s most decorated and esteemed teams competing for one of the sport’s most coveted titles. World Champion and reigning race champion Peter Sagan of Tinkoff roared to victory in a bunch sprint to the finish line in Mission Beach, San Diego, putting him back into the yellow leader jersey he wore at the race’s conclusion last year.
To view the multimedia release go to:
http://www.multivu.com/players/English/7831951-amgen-tour-of-california/
The Amgen Foundation announced today that it will invest more than $4 million to support and strengthen the Amgen Biotech Experience program across the United States, Puerto Rico, United Kingdom and Ireland. The Amgen Biotech Experience includes an engaging series of labs that effectively bring biotechnology into classrooms. This new commitment will also strengthen the program’s alignment with the United States’ Next Generation Science Standards, which are focused on engaging students in more authentic science learning experiences. With the support of Education Development Center, Inc. (EDC), the global nonprofit leading the Amgen Biotech Experience Program Office, the investment is expected to empower 1,000 teachers who will reach more than 150,000 new students with the labs over the next two years.
“We are very excited to extend our commitment to the Amgen Biotech Experience, a program that began 25 years ago, with the intent to ignite a deep passion for innovation and scientific discovery in students,” said Robert A. Bradway, chairman and chief executive officer of Amgen. “This program, which provides advanced biotech curriculum and professional-grade lab equipment at no cost to schools, has opened countless students’ eyes to the world of biotechnology, fueling potential long term advancements to both medicine and society.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7414055-amgen-biotech-experience-grant/
The Amgen Foundation today announced $2.5 million in new grants for the Amgen Biotech Experience, an innovative science education program, bringing the total committed to nearly $8 million since the program’s inception in 1990. The Amgen Biotech Experience provides a real-world biotech lab experience to middle and high schools in Amgen’s U.S. and United Kingdom (U.K.) communities and will engage more than 50,000 students this year. Education Development Center, Inc. (EDC), a global nonprofit organization that creates learning opportunities around the world, has also been named Program Office to oversee the program’s implementation and facilitate its continued development.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/59861-amgen-biotech-experience-lab-science-education-grants-for-students
Emmy® and Tony® award-winning actress Blythe Danner and Amgen (NASDAQ:AMGN) today launch Act 2 Reduce Fractures™, an educational campaign for women with postmenopausal osteoporosis at increased risk for fractures. Earlier this year, Danner was diagnosed with postmenopausal osteoporosis at increased risk for fractures and wants to encourage women like her to educate themselves, take action and speak to their doctors to learn all they can about helping to strengthen their bones. The campaign is being supported by American Bone Health, the Global Healthy Living Foundation and the Older Women’s League.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/amgen/48052/
